An extended cost-effectiveness analysis of schizophrenia treatment in India under universal public finance
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-7547
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
An extended cost-effectiveness analysis of schizophrenia treatment in India under universal public finance ; volume:14 ; number:1 ; day:8 ; month:7 ; year:2016 ; pages:1-11 ; date:12.2016
Cost effectiveness and resource allocation ; 14, Heft 1 (8.7.2016), 1-11, 12.2016
- Urheber
-
Raykar, Neha
- Beteiligte Personen und Organisationen
-
Nigam, Aditi
Chisholm, Dan
SpringerLink (Online service)
- DOI
-
10.1186/s12962-016-0058-z
- URN
-
urn:nbn:de:1111-2016071122475
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Raykar, Neha
- Nigam, Aditi
- Chisholm, Dan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Universal distances for extended persistence
On the cost-effectiveness of PRAMs : extended abstract
Development finance for universal energy access
An extended macro-finance model with financial factors
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
Effects of paliperidone extended release on the symptoms and functioning of schizophrenia
Disrupted local functional connectivity in schizophrenia: An updated and extended meta-analysis
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Universal Metrics for Climate Change Adaptation Finance? A Cautionary Tale
A cost-effectiveness analysis of a universal, preventative-focused, parent and infant programme
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Universal distances for extended persistence
On the cost-effectiveness of PRAMs : extended abstract
Development finance for universal energy access
An extended macro-finance model with financial factors
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
Effects of paliperidone extended release on the symptoms and functioning of schizophrenia
Disrupted local functional connectivity in schizophrenia: An updated and extended meta-analysis
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Universal Metrics for Climate Change Adaptation Finance? A Cautionary Tale
A cost-effectiveness analysis of a universal, preventative-focused, parent and infant programme
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Universal distances for extended persistence
On the cost-effectiveness of PRAMs : extended abstract
Development finance for universal energy access
An extended macro-finance model with financial factors
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
Effects of paliperidone extended release on the symptoms and functioning of schizophrenia
Disrupted local functional connectivity in schizophrenia: An updated and extended meta-analysis
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Universal Metrics for Climate Change Adaptation Finance? A Cautionary Tale